Inari Medical Stock Price, News & Analysis (NASDAQ:NARI) $62.15 -0.62 (-0.99%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$60.50▼$62.9950-Day Range$48.30▼$68.0652-Week Range$47.81▼$73.10Volume577,386 shsAverage Volume795,760 shsMarket Capitalization$3.58 billionP/E RatioN/ADividend YieldN/APrice Target$82.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Inari Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside31.9% Upside$82.00 Price TargetShort InterestBearish9.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 3 Articles This WeekInsider TradingSelling Shares$9.56 M Sold Last QuarterProj. Earnings Growth-87.50%From $0.08 to $0.01 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.88 out of 5 starsMedical Sector692nd out of 948 stocksMedical Devices Industry13th out of 17 stocks 3.4 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $82.00, Inari Medical has a forecasted upside of 31.9% from its current price of $62.15.Amount of Analyst CoverageInari Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted9.62% of the float of Inari Medical has been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Inari Medical has recently decreased by 4.65%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 3 news articles for Inari Medical this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for NARI on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.MarketBeat Follows4 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold 231.35% more of their company's stock than they have bought. Specifically, they have bought $2,885,760.00 in company stock and sold $9,561,843.00 in company stock.Percentage Held by Insiders13.70% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.75% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to decrease by -87.50% in the coming year, from $0.08 to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -1,035.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -1,035.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 8.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inari Medical Stock (NASDAQ:NARI)Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesNovember 7, 2023 | marketbeat.comAfter blowout earnings, Integer may be headed to new highs (NARI)A growth strategy that includes both in-house expansion and acquisition activity could keep Integer Holdings Corporation's run going well into 2024.December 1, 2023 | finance.yahoo.comInari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?December 6, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 30, 2023 | bizjournals.comMedical device giant Johnson & Johnson swallows small North Bay companyNovember 28, 2023 | msn.comInari Medical enrols first patient in FlowTriever System trialNovember 24, 2023 | morningstar.comInari Medical Inc Ordinary SharesNovember 21, 2023 | finance.yahoo.comBill Hoffman Joins Magenta Medical's Board of DirectorsNovember 18, 2023 | finance.yahoo.comInsider Sell Alert: Director William Hoffman Sells 25,000 Shares of Inari Medical Inc (NARI)December 6, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 18, 2023 | finanznachrichten.deInari Medical, Inc.: Inari Medical Closes Acquisition of LimFlowNovember 15, 2023 | finance.yahoo.comInari Medical Closes Acquisition of LimFlowNovember 15, 2023 | finance.yahoo.comReasons to Retain Inari Medical (NARI) in Your Portfolio NowNovember 7, 2023 | seekingalpha.comInari Medical, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 7, 2023 | seekingalpha.comInari Medical: Top Buy For End Of 2023 And 2024November 6, 2023 | uk.finance.yahoo.comInari Medical, Inc. (NARI) Loses -27.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerNovember 6, 2023 | markets.businessinsider.comInari Medical: Buy Recommendation Based on Leadership, Strong Growth, and Strategic AcquisitionsNovember 3, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Inari Medical (NARI) and Nevro Corp (NVRO)November 3, 2023 | finance.yahoo.comInari Medical, Inc. (NASDAQ:NARI) Q3 2023 Earnings Call TranscriptNovember 2, 2023 | msn.comInari Medical agrees to buy LimFlow in $415m dealNovember 2, 2023 | bizjournals.comMedical device to rescue legs from amputation wins approval, then company is soldNovember 2, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Inari Medical (NARI) and Revance Therapeutics (RVNC)November 2, 2023 | finance.yahoo.comQ3 2023 Inari Medical Inc Earnings CallNovember 2, 2023 | finance.yahoo.comExact Sciences (EXAS) Q3 Earnings Beat, Gross Margin RisesNovember 1, 2023 | marketwatch.comInari Medical to Acquire LimFlow for $250MNovember 1, 2023 | finance.yahoo.comLimFlow Announces Agreement to Be Acquired by Inari MedicalNovember 1, 2023 | msn.comInari Medical announces deal to acquire LimFlow for $250MNovember 1, 2023 | finance.yahoo.comInari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlowSee More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2023Today12/05/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,100Year FoundedN/APrice Target and Rating Average Stock Price Target$82.00 High Stock Price Target$100.00 Low Stock Price Target$65.00 Potential Upside/Downside+31.9%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E Ratio776.88 P/E GrowthN/ANet Income$-29,270,000.00 Net Margins-0.59% Pretax Margin0.56% Return on Equity-0.64% Return on Assets-0.53% Debt Debt-to-Equity RatioN/A Current Ratio7.10 Quick Ratio6.49 Sales & Book Value Annual Sales$469.31 million Price / Sales7.63 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book8.00Miscellaneous Outstanding Shares57,590,000Free Float49,700,000Market Cap$3.58 billion OptionableNot Optionable Beta0.92 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 49)CEO, President & Director Comp: $863.78kMr. Mitchell C. Hill (Age 64)Chief Financial Officer Comp: $811.08kDr. Thomas M. Tu M.D. (Age 50)Chief Medical Officer Comp: $812.94kMr. Paul A. Koehn (Age 60)Senior Vice President of Operations Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentMr. John Hsu C.F.A.Vice President of Investor RelationsMs. Angela AhmadGeneral Counsel & SecretaryMr. Eric KhairySenior Vice President of MarketingMr. John R. Borrell (Age 56)Senior Vice President of Sales Ms. Tara DunnSenior Vice President of Clinical Affairs & Market DevelopmentMore ExecutivesKey CompetitorsCantel MedicalNYSE:CMDCONMEDNYSE:CNMDICU MedicalNASDAQ:ICUINuVasiveNASDAQ:NUVAPROCEPT BioRoboticsNASDAQ:PRCTView All CompetitorsInsiders & InstitutionsWellington Management Group LLPSold 373,403 shares on 12/1/2023Ownership: 8.849%American Century Companies Inc.Bought 18,166 shares on 11/30/2023Ownership: 0.735%Deutsche Bank AGSold 197,104 shares on 11/24/2023Ownership: 0.104%Polar Capital Holdings PlcSold 3,386 shares on 11/22/2023Ownership: 0.021%Graham Capital Management L.P.Bought 1,621 shares on 11/22/2023Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions NARI Stock Analysis - Frequently Asked Questions Should I buy or sell Inari Medical stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NARI shares. View NARI analyst ratings or view top-rated stocks. What is Inari Medical's stock price target for 2024? 5 analysts have issued 1 year price targets for Inari Medical's shares. Their NARI share price targets range from $65.00 to $100.00. On average, they predict the company's share price to reach $82.00 in the next twelve months. This suggests a possible upside of 31.9% from the stock's current price. View analysts price targets for NARI or view top-rated stocks among Wall Street analysts. How have NARI shares performed in 2023? Inari Medical's stock was trading at $63.56 at the beginning of the year. Since then, NARI stock has decreased by 2.2% and is now trading at $62.15. View the best growth stocks for 2023 here. When is Inari Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024. View our NARI earnings forecast. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) released its quarterly earnings results on Wednesday, November, 1st. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.00 by $0.05. The firm earned $126.37 million during the quarter, compared to analysts' expectations of $121.92 million. Inari Medical had a negative trailing twelve-month return on equity of 0.64% and a negative net margin of 0.59%. The business's revenue was up 31.4% on a year-over-year basis. During the same period in the previous year, the company earned ($0.19) EPS. What ETFs hold Inari Medical's stock? ETFs with the largest weight of Inari Medical (NASDAQ:NARI) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Principal Healthcare Innovators ETF (BTEC) and IQ Healthy Hearts ETF (HART).iShares U.S. Medical Devices ETF (IHI). What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY). When did Inari Medical IPO? (NARI) raised $110 million in an IPO on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Inari Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Wellington Management Group LLP (8.85%), Brown Advisory Inc. (2.52%), JPMorgan Chase & Co. (2.35%), Morgan Stanley (1.57%), Allspring Global Investments Holdings LLC (1.31%) and Northern Trust Corp (1.14%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Stanley Tang, Thomas Tu and William Hoffman. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:NARI) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.